Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Thruvision Group (THRU) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Sell Checkit (CKT) by Steve Moore in ShareProphets
- Buy SEGRO (SGRO) by Jefferies
- Buy Chesnara (CSN) by Tom Winnifrith in ShareProphets
- Buy Chesnara (CSN) by Steve Moore in ShareProphets
- Avoid Boohoo Group (BOO) by Steve Moore in ShareProphets
- Buy Mondi (MNDI) by UBS
- Neutral Glencore (GLEN) by UBS
- Buy Baltic Classifieds Group (BCG) by Deutsche Bank
- Buy Auto Trader Group (AUTO) by Deutsche Bank
- Buy Rightmove (RMV) by Deutsche Bank
- Buy Sage Group (SGE) by Shore Capital
- Buy Greggs (GRG) by Cliff D'Arcy in The Motley Fool
- Buy Linde (0M2B) by Berenberg
- Underweight GSK (GSK) by Barclays
- Neutral Glencore (GLEN) by JP Morgan
- Overweight Rio Tinto (RIO) by JP Morgan
- Avoid Crimson Tide (TIDE) by Steve Moore in ShareProphets
- Avoid YouGov (YOU) by Steve Moore in ShareProphets
Indivior (INDV) Share Price
Health Care Sector
NOTE: This is based on 102 open tips for Indivior (INDV)
| Latest Bid : 1,248.00p | Latest Ask : 1,250.00p |
| High Today : 1,264.00p | Low Today : 1,230.00p |
| This Years High : 1,264.00p | This Years Low : 576.50p |
| Volume : 304,722 | MKT Cap : £1547.5M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Indivior (INDV) Overview
Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.Indivior (INDV) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2018-10-11 09:00:00 11/10/2018 | 10.59% |
| Buy | Numis | Premium Only | 2018-09-27 12:10:00 27/09/2018 | -71.27% |
| Avoid | Miles Costello | Premium Only | 2018-09-11 08:30:00 11/09/2018 | 29.72% |
| Buy | Numis | Premium Only | 2018-07-30 14:20:00 30/07/2018 | -48.43% |
| Buy | Numis | Premium Only | 2018-07-27 11:05:00 27/07/2018 | -52.77% |
Indivior (INDV) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Qube Research & Technologies Limited | 1.4% | 04/11/2025 |
| Citadel Advisors LLC | 0.53% | 26/09/2025 |
| Millennium Capital (DIFC) Limited | 1.03% | 22/07/2025 |
| Latest Bid : 1,248.00p | Latest Ask : 1,250.00p |
| High Today : 1,264.00p | Low Today : 1,230.00p |
| This Years High : 1,264.00p | This Years Low : 576.50p |
| Volume : 304,722 | MKT Cap : £1547.5M |
Indivior Overview
Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Indivior Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2018-10-11 09:00:00 11/10/2018 | 10.59% |
| Buy | Numis | Premium Only | 2018-09-27 12:10:00 27/09/2018 | -71.27% |
| Avoid | Miles Costello | Premium Only | 2018-09-11 08:30:00 11/09/2018 | 29.72% |
| Buy | Numis | Premium Only | 2018-07-30 14:20:00 30/07/2018 | -48.43% |
| Buy | Numis | Premium Only | 2018-07-27 11:05:00 27/07/2018 | -52.77% |